the aid library

Nepal HIVision 2020. Ending the AIDS epidemic as a public health threat, by 2030
recommended

Government of Nepal; Ministry of Health; National Centre for AIDS and STD Control (2016) C1

National HIV Strategic Plan 2016-2021

Checklist and reference list for developing and reviewing a national strategic plan for HIV

UNAIDS (2020) C_WHO

The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). Part A applies to all countries and contains situation and response ... more

Cameroon: The Perceptions, Problems, and Possibilities of Cameroonians with Mental Disabilities: A Case study of Le Centre National de Réhabilitation des Personnes Handicapées de Yaoundé

Lauren Miller SIT G aduate Ins tituteSIT Study Abroad (2012) CC

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to ... reduce antimicrobial overuse. A systematic evidence map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Incidence and prevalence of type 1 diabetes in Africa: a systematic review and meta-analysis protocol

Katte, J.C.; Agoons, B.B.; Dimala, C.A.; et al. BMJ Journals (2022) CC

Type 1 diabetes is reported to have significant mortality in Africa. However, there is a paucity of data on pooled estimates of its incidence and prevalence in Africa. This first systematic review and meta-analysis will be conducted to determine the ... more

Managment of Tuberculosis Training Health Facility Staff. Part A

World Health Organization,et al. (2010) C_WHO

Second Edition

Recherche des Contacts Pendant une Flambée de Maladie à Virus Ebola

World Health Organization, Regional Office for Africa; (2014)

Engager les services d’Entreprises de sécurité privées - Orientations à l’intention des organisations non gouvernementales

Max Glaser, European Interagency Security Forum (EISF) Forum Inter-agences Européen sur la Sécurité (2011) C2

Au cours des dix dernières années, les ONG humanitaires ont fait de plus en plus fréquemment appel aux Entreprises de sécurité privées (ESP). On observe l’existence d’un écart entre la manière dont les ONG utilisent les ESP dans la réalité et la régulation d’une telle relation. Ces ... more

HEARTS Paquete técnico para el manejo de las enfermedades cardiovasculares en la atención primaria de salud. Acceso a medicamentos y tecnologías esenciales

Pan American Health Organization (PAHO) (2018) C_WHO

Los módulos que conforman el paquete técnico HEARTS están dirigidos a los formuladores de políticas públicas y gerentes, directores o coordinadores de programas a diferentes niveles dentro de ... more

Evaluation du secteur privé de la santé au Sénégal a travers quelques examples d'offres de produits et de préstations de services

Bettina B., J. Barnes, A. Carmona United States Agency for International Development (2016) C2

Cette évaluation est axée en premier lieu sur la planification familiale et en second lieu sur la santé maternelle, néonatale et de l’enfant (SMNE), le VIH/sida, le paludisme et la nutrition. L’évaluation avait les objectifs suivants : 1. Produire un aperçu des parties prenantes du secte ... more

Factors influencing the use of malaria prevention strategies by women in Senegal: a cross-sectional study

Mbengue M. A. S., A. K. Bei, A. Mboup Malaria Journal (2017) C2

The World Health Organization (WHO) recommends the use of insecticide-treated nets (ITNs) and intermittent preventive treatment in pregnancy (IPTp) as a cost-effective intervention for the prevention of malaria during pregnancy in endemic areas. Thi ... more

Methicillin-ResistantStaphylococcus aureus(MRSA):Prevalence and Antimicrobial Sensitivity Pattern among Patients—A Multicenter Study in Asmara, Eritrea

Yohaness Garoy E., Y. Berhane Gebreab, O. Okoth Achila et al. Hindawi (2018) C2

Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases inclu ... more

Conference: "Global Responsibility 2030: The MDGs and the Post-2015-Process as a challenge for the Universal Church

Turkson P. Pontificium Consilium de Iustitia et Pace (2016) C1

Catholic social teaching, integral ecology and sustainable development

Le port du masque de façon APPROPRIEE peut contribuer à prévenir la transmission du COVID19 aux autres

Africa Centres for Disease Control and Prevention (Africa CDC) (2020) CC

The Essential Public Health Functions in the Americas: A Renewal for the 21st Century. Conceptual Framework and Description

Pan American Health Organisation PAHO (2021) C_WHO

The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides ... more

Developing and Strengthening Community Health Worker Programs at Scale, A Reference Guide for Program Managers and Policy Makers

USAID, MCHIP (2013) CC

Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them as effec ... more

Ebola and beyond: Equality, sustainability, security - interlaced challenges in a global development era

Leach, M. (2014)

This paper, originally presented as a Sussex Development Lecture, asks how the Ebola crisis might offer a lens to reflect on interlaced challenges around curbing inequalities, accelerating sustainab ... more

Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Neurology Collaborators (2019) CC

Lancet Neurol 2019 Volume 18, ISSUE 5, P459-480, May 01, 2019 Published OnlineMarch 14, 2019 http://dx.doi.org/10.1016/ S1474-4422(18)30499-X